| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8786018 | Clinical Oncology | 2018 | 9 Pages |
Abstract
DCC was tolerable and feasible with promising efficacy, and may be suitable for future investigation in both first-line metastatic and neoadjuvant settings.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Gollins, S. Massalha, A. Mullard, R.M. Williams, A. Lloyd, J. Morris, A. Garcia-Alonso,